Report Detail

Medical Devices & Consumables Global Needle-Free Drug Delivery Systems Market Insights and Forecast to 2026

  • RnM4170880
  • |
  • 27 August, 2020
  • |
  • Global
  • |
  • 116 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Needle-Free Drug Delivery Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Needle-Free Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Needle-Free Drug Delivery Systems market is segmented into
Jet-based
Spring-based
Laser-based

Segment by Application, the Needle-Free Drug Delivery Systems market is segmented into
Hospital
Clinic
Other

Regional and Country-level Analysis
The Needle-Free Drug Delivery Systems market is analysed and market size information is provided by regions (countries).
The key regions covered in the Needle-Free Drug Delivery Systems market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Needle-Free Drug Delivery Systems Market Share Analysis

Needle-Free Drug Delivery Systems market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Needle-Free Drug Delivery Systems by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Needle-Free Drug Delivery Systems business, the date to enter into the Needle-Free Drug Delivery Systems market, Needle-Free Drug Delivery Systems product introduction, recent developments, etc.
The major vendors covered:
Antares Pharma
Pharmajet
Optinose
Valeritas
Crossject
Injex Pharma
3M Pharmaceuticals
Becton Dickinson (BD)
MedImmune
Mystic Pharmaceuticals
Zogenix


1 Study Coverage

  • 1.1 Needle-Free Drug Delivery Systems Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Needle-Free Drug Delivery Systems Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Needle-Free Drug Delivery Systems Market Size Growth Rate by Type
    • 1.4.2 Jet-based
    • 1.4.3 Spring-based
    • 1.4.4 Laser-based
  • 1.5 Market by Application
    • 1.5.1 Global Needle-Free Drug Delivery Systems Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Needle-Free Drug Delivery Systems Market Size, Estimates and Forecasts
    • 2.1.1 Global Needle-Free Drug Delivery Systems Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Needle-Free Drug Delivery Systems Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Needle-Free Drug Delivery Systems Production Estimates and Forecasts 2015-2026
  • 2.2 Global Needle-Free Drug Delivery Systems, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Needle-Free Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Needle-Free Drug Delivery Systems Manufacturers Geographical Distribution
  • 2.4 Key Trends for Needle-Free Drug Delivery Systems Markets & Products
  • 2.5 Primary Interviews with Key Needle-Free Drug Delivery Systems Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Needle-Free Drug Delivery Systems Manufacturers by Production Capacity
    • 3.1.1 Global Top Needle-Free Drug Delivery Systems Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Needle-Free Drug Delivery Systems Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Needle-Free Drug Delivery Systems Manufacturers Market Share by Production
  • 3.2 Global Top Needle-Free Drug Delivery Systems Manufacturers by Revenue
    • 3.2.1 Global Top Needle-Free Drug Delivery Systems Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Needle-Free Drug Delivery Systems Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Needle-Free Drug Delivery Systems Revenue in 2019
  • 3.3 Global Needle-Free Drug Delivery Systems Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Needle-Free Drug Delivery Systems Production by Regions

  • 4.1 Global Needle-Free Drug Delivery Systems Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Needle-Free Drug Delivery Systems Regions by Production (2015-2020)
    • 4.1.2 Global Top Needle-Free Drug Delivery Systems Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Needle-Free Drug Delivery Systems Production (2015-2020)
    • 4.2.2 North America Needle-Free Drug Delivery Systems Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Needle-Free Drug Delivery Systems Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Needle-Free Drug Delivery Systems Production (2015-2020)
    • 4.3.2 Europe Needle-Free Drug Delivery Systems Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Needle-Free Drug Delivery Systems Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Needle-Free Drug Delivery Systems Production (2015-2020)
    • 4.4.2 China Needle-Free Drug Delivery Systems Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Needle-Free Drug Delivery Systems Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Needle-Free Drug Delivery Systems Production (2015-2020)
    • 4.5.2 Japan Needle-Free Drug Delivery Systems Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Needle-Free Drug Delivery Systems Import & Export (2015-2020)

5 Needle-Free Drug Delivery Systems Consumption by Region

  • 5.1 Global Top Needle-Free Drug Delivery Systems Regions by Consumption
    • 5.1.1 Global Top Needle-Free Drug Delivery Systems Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Needle-Free Drug Delivery Systems Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Needle-Free Drug Delivery Systems Consumption by Application
    • 5.2.2 North America Needle-Free Drug Delivery Systems Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Needle-Free Drug Delivery Systems Consumption by Application
    • 5.3.2 Europe Needle-Free Drug Delivery Systems Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Needle-Free Drug Delivery Systems Consumption by Application
    • 5.4.2 Asia Pacific Needle-Free Drug Delivery Systems Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Needle-Free Drug Delivery Systems Consumption by Application
    • 5.5.2 Central & South America Needle-Free Drug Delivery Systems Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Needle-Free Drug Delivery Systems Consumption by Application
    • 5.6.2 Middle East and Africa Needle-Free Drug Delivery Systems Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Needle-Free Drug Delivery Systems Market Size by Type (2015-2020)
    • 6.1.1 Global Needle-Free Drug Delivery Systems Production by Type (2015-2020)
    • 6.1.2 Global Needle-Free Drug Delivery Systems Revenue by Type (2015-2020)
    • 6.1.3 Needle-Free Drug Delivery Systems Price by Type (2015-2020)
  • 6.2 Global Needle-Free Drug Delivery Systems Market Forecast by Type (2021-2026)
    • 6.2.1 Global Needle-Free Drug Delivery Systems Production Forecast by Type (2021-2026)
    • 6.2.2 Global Needle-Free Drug Delivery Systems Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Needle-Free Drug Delivery Systems Price Forecast by Type (2021-2026)
  • 6.3 Global Needle-Free Drug Delivery Systems Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Needle-Free Drug Delivery Systems Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Needle-Free Drug Delivery Systems Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Antares Pharma
    • 8.1.1 Antares Pharma Corporation Information
    • 8.1.2 Antares Pharma Overview
    • 8.1.3 Antares Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Antares Pharma Product Description
    • 8.1.5 Antares Pharma Related Developments
  • 8.2 Pharmajet
    • 8.2.1 Pharmajet Corporation Information
    • 8.2.2 Pharmajet Overview
    • 8.2.3 Pharmajet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Pharmajet Product Description
    • 8.2.5 Pharmajet Related Developments
  • 8.3 Optinose
    • 8.3.1 Optinose Corporation Information
    • 8.3.2 Optinose Overview
    • 8.3.3 Optinose Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Optinose Product Description
    • 8.3.5 Optinose Related Developments
  • 8.4 Valeritas
    • 8.4.1 Valeritas Corporation Information
    • 8.4.2 Valeritas Overview
    • 8.4.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Valeritas Product Description
    • 8.4.5 Valeritas Related Developments
  • 8.5 Crossject
    • 8.5.1 Crossject Corporation Information
    • 8.5.2 Crossject Overview
    • 8.5.3 Crossject Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Crossject Product Description
    • 8.5.5 Crossject Related Developments
  • 8.6 Injex Pharma
    • 8.6.1 Injex Pharma Corporation Information
    • 8.6.2 Injex Pharma Overview
    • 8.6.3 Injex Pharma Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Injex Pharma Product Description
    • 8.6.5 Injex Pharma Related Developments
  • 8.7 3M Pharmaceuticals
    • 8.7.1 3M Pharmaceuticals Corporation Information
    • 8.7.2 3M Pharmaceuticals Overview
    • 8.7.3 3M Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 3M Pharmaceuticals Product Description
    • 8.7.5 3M Pharmaceuticals Related Developments
  • 8.8 Becton Dickinson (BD)
    • 8.8.1 Becton Dickinson (BD) Corporation Information
    • 8.8.2 Becton Dickinson (BD) Overview
    • 8.8.3 Becton Dickinson (BD) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 Becton Dickinson (BD) Product Description
    • 8.8.5 Becton Dickinson (BD) Related Developments
  • 8.9 MedImmune
    • 8.9.1 MedImmune Corporation Information
    • 8.9.2 MedImmune Overview
    • 8.9.3 MedImmune Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 MedImmune Product Description
    • 8.9.5 MedImmune Related Developments
  • 8.10 Mystic Pharmaceuticals
    • 8.10.1 Mystic Pharmaceuticals Corporation Information
    • 8.10.2 Mystic Pharmaceuticals Overview
    • 8.10.3 Mystic Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Mystic Pharmaceuticals Product Description
    • 8.10.5 Mystic Pharmaceuticals Related Developments
  • 8.11 Zogenix
    • 8.11.1 Zogenix Corporation Information
    • 8.11.2 Zogenix Overview
    • 8.11.3 Zogenix Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Zogenix Product Description
    • 8.11.5 Zogenix Related Developments

9 Needle-Free Drug Delivery Systems Production Forecast by Regions

  • 9.1 Global Top Needle-Free Drug Delivery Systems Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Needle-Free Drug Delivery Systems Regions Forecast by Production (2021-2026)
  • 9.3 Key Needle-Free Drug Delivery Systems Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Needle-Free Drug Delivery Systems Consumption Forecast by Region

  • 10.1 Global Needle-Free Drug Delivery Systems Consumption Forecast by Region (2021-2026)
  • 10.2 North America Needle-Free Drug Delivery Systems Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Needle-Free Drug Delivery Systems Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Needle-Free Drug Delivery Systems Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Needle-Free Drug Delivery Systems Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Needle-Free Drug Delivery Systems Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Needle-Free Drug Delivery Systems Sales Channels
    • 11.2.2 Needle-Free Drug Delivery Systems Distributors
  • 11.3 Needle-Free Drug Delivery Systems Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Needle-Free Drug Delivery Systems Industry
  • 12.2 Market Trends
  • 12.3 Market Opportunities and Drivers
  • 12.4 Market Challenges
  • 12.5 Needle-Free Drug Delivery Systems Market Risks/Restraints
  • 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Needle-Free Drug Delivery Systems Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on Needle-Free Drug Delivery Systems. Industry analysis & Market Report on Needle-Free Drug Delivery Systems is a syndicated market report, published as Global Needle-Free Drug Delivery Systems Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Needle-Free Drug Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,905.30
    5,857.95
    7,810.60
    4,557.00
    6,835.50
    9,114.00
    749,112.00
    1,123,668.00
    1,498,224.00
    408,807.00
    613,210.50
    817,614.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report